Sana Biotechnology Announces Multiple Preclinical Data Presentations to Showcase Its Hypoimmune Platform, Including in Type 1 Diabetes, at the Upcoming ISSCR 2022 Annual Meeting

Author's Avatar
Jun 23, 2022

New data highlighting the potential of human islet cell transplantation for type 1 diabetes will be presented